Bartoletti Stefano, Santangeli Pasquale, DI Biase Luigi, Natale Andrea
Institute of Cardiology, Catholic University of the Sacred Heart, Rome (Italy).
Cardiac Arrhythmia Service, Stanford University School of Medicine, Stanford (CA).
J Atr Fibrillation. 2013 Jun 30;6(1):851. doi: 10.4022/jafib.851. eCollection 2013 Jun-Jul.
Patients with mechanical "hardware" in the heart, such as those with mechanical cardiac valves or atrial septal closure devices, represent a population at high risk of developing AF. Catheter ablation of AF in these subjects might represent a challenge, due to the perceived higher risk of complications associated with the presence of intracardiac mechanical devices. Accordingly, such patients were excluded or poorly represented in major trials proving the benefit of catheter ablation for the rhythm-control of AF. However, recent evidence supports the concept that catheter ablation procedures might be equally effective in these patients, without a significant increase in the risk of procedural complications. This review will summarize the current state-of-the-art on catheter ablation of AF in patients with mechanical "hardware" in the heart.
心脏植入机械“硬件”的患者,如那些植入机械心脏瓣膜或房间隔封堵装置的患者,是发生房颤的高危人群。由于人们认为心内机械装置会增加并发症风险,对这些患者进行房颤导管消融可能是一项挑战。因此,在证明房颤导管消融对节律控制有益的主要试验中,此类患者被排除在外或代表性不足。然而,最近的证据支持这样一种观点,即导管消融手术在这些患者中可能同样有效,且手术并发症风险不会显著增加。本综述将总结目前心脏植入机械“硬件”的房颤患者导管消融的最新情况。